HomeoPet® is excited to announce that it will, in the near future, be introducing a cat specific range, these will be available over the counter, for further info see below.
There will be a number of presentations, detailing HomeoPet®'s research progress, the most important of these will be presented by Kirsty Seksel at the IVBM.
And over the coming months Tom Farrington, M.V.B., M.R.C.V.S., Vet MFHom, the man behind the medicine, will be in the UK, where we are going to be introducing the HomeoPet® product range for over the counter, and veterinary sale.
|
We have two big pieces of news as regards the HomeoPet® product range, firstly the introduction of the HomeoPet® cat specific range is about to take place. This will allow cat owners to purchase products specifically catered to their pet's needs. This cat range will be as extensive as the current HomeoPet® range, but will be designed specifically for our feline friends. Secondly and perhaps most excitingly we are introducing the HomeoPet® product range into the United Kingdom over the coming months, and over time we will be expanding the range available in the U.K. to include all of HomeoPet®'s products. We will be offering exactly the same level of service and integrity in the U.K. as we have done for the past fifteen years in the United States, Tom Farrington will be in the U.K. from June 14th onwards, and will be holding town hall meetings and veterinary meetings to help introduce you to HomeoPet®'s healing solutions. |
HomeoPet® is looking to take a number of big steps in it's research programs, by the end of June we plan to have the first wave of research published, as well as wrapping up the final stages of our fourth trial over the course of the summer. The trials in the U.K. made remarkable progress over the course of the last year and we are very excited about moving onto the next stage of our trials. In Australia we have had similar success and our excited to say that we will be presenting an abstract detailing some of the methods and goals behind our trials there at the IVBM in Edinburgh in October of this year. To read an abstract of this presentation please visit the research section of our site and select the Australian trials. These updates can be emailed to you directly by subscribing to our mailing list, which is available by clicking here. |
|